Abstract
Obesity is an energy imbalance that occurs due to a lack of energy intake and consumption. We studied the variability of the Q223R polymorphism of the LEPR gene in the Yakut population and the relationship with body mass index (BMI) and abdominal obesity in a sample of Yakuts (n=336), consisting of individuals with obesity (n=185) and normal weight (n=151). For genotyping, we used the classical methods of PCR-RFLP analysis. A comparative analysis of the obtained data on the frequencies of alleles and genotypes with data on other populations of the world was also carried out. The G variant allele frequency was 79.5% in normal weight patients and 82.7% in obese patients. Genotype analysis showed a high frequency of genotypes GG - 64.2% and GA - 30.5% in the group with normal BMI and GG - 69.7% and GA - 25.9% in the group with high BMI. There was no significant difference in the frequency of alleles and genotypes of the Q223R polymorphism between the groups. It was established that the frequency of the G allele of the Yakuts (79.5%) with the populations of East Asia (86.9%). When analyzing the average anthropometric values, depending on the genotype, a statistically significant difference in waist circumference was found in persons with abdominal obesity (p = 0.03), so it was greater in carriers of the heterozygous AG genotype than in carriers of the GG genotype.
In conclusion, our study demonstrates that SNP Q223R (LEPR) is possible and has some effect on anthropometric parameters in the Yakut population, but differs from studies conducted on samples of European ethnicity. It can be assumed that the accumulation of the G allele of the Q223R polymorphism (LEPR) in the Yakut population, as well as in the populations of East Asia, is probably the result of metabolic adaptation to living conditions in a non-tropical climate.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the local committee on biomedical ethics at the Yakutian Scientific Center of Clinical Medicine. The study was carried out as part of the research project Study of the genetic structure and load of hereditary pathology in populations of the Republic of Sakha (Yakutia).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data obtained in this study are available upon reasonable request from the authors. All data obtained in this work are contained in the manuscript. All available data is available, except for bioresource collection data containing confidential information
